X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (64) 64
male (53) 53
middle aged (50) 50
female (47) 47
adult (45) 45
hematology (44) 44
index medicus (35) 35
aged (24) 24
oncology (18) 18
adolescent (17) 17
transplantation (17) 17
chemotherapy (16) 16
treatment outcome (16) 16
risk factors (12) 12
therapy (12) 12
research (11) 11
transplantation, homologous (11) 11
blasting (10) 10
bone-marrow-transplantation (10) 10
cancer (10) 10
disease-free survival (10) 10
heating (10) 10
hematopoietic stem cell transplantation - adverse effects (10) 10
lighting (10) 10
mechanical engineering (10) 10
retrospective studies (10) 10
stem cells (10) 10
weapons (10) 10
young adult (10) 10
clinical neurology (9) 9
engine plants in general (9) 9
machines or engines in general (9) 9
positive displacement machines for liquids (9) 9
prospective studies (9) 9
pumps for liquids or elastic fluids (9) 9
rotary-piston or oscillating-piston machines or engines (9) 9
rotary-piston, or oscillating-piston, positive-displacementmachines for liquids (9) 9
rotary-piston, or oscillating-piston, positive-displacementpumps (9) 9
steam engines (9) 9
stem cell transplantation (9) 9
survival (9) 9
abridged index medicus (8) 8
medicine & public health (8) 8
aged, 80 and over (7) 7
analysis (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
bone marrow transplantation (7) 7
case-control studies (7) 7
clinical trials (7) 7
hematopoietic stem cell transplantation (7) 7
insomnia (7) 7
leukemia (7) 7
prognosis (7) 7
time factors (7) 7
transplantation, autologous (7) 7
trial (7) 7
acute disease (6) 6
cells (6) 6
follow-up studies (6) 6
recurrence (6) 6
risk (6) 6
sleep (6) 6
stem-cell transplantation (6) 6
survival analysis (6) 6
bone-marrow transplantation (5) 5
chronic myelogenous leukemia (5) 5
colony-stimulating factor (5) 5
diagnosis (5) 5
disease (5) 5
expression (5) 5
graft vs host disease (5) 5
health aspects (5) 5
hematopoietic stem cell transplantation - methods (5) 5
immunology (5) 5
lymphomas (5) 5
neurosciences (5) 5
patients (5) 5
polysomnography (5) 5
psychiatry (5) 5
rituximab (5) 5
versus-host-disease (5) 5
acute lymphoblastic-leukemia (4) 4
adult patients (4) 4
age (4) 4
allogeneic stem cell transplantation (4) 4
care and treatment (4) 4
child (4) 4
combined modality therapy (4) 4
consolidation therapy (4) 4
depression (4) 4
induction chemotherapy - methods (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - therapy (4) 4
medicine, general & internal (4) 4
methotrexate - administration & dosage (4) 4
mortality (4) 4
recipients (4) 4
remission induction (4) 4
serum (4) 4
sleep initiation and maintenance disorders - diagnosis (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 11, pp. 1036 - 1047
Summary Background High-dose methotrexate is the standard of care for patients with newly diagnosed primary CNS lymphoma. The role of whole brain radiotherapy... 
Hematology, Oncology and Palliative Medicine | DEFERRED RADIOTHERAPY | 1ST-LINE TREATMENT | ONCOLOGY-GROUP | COMBINED-MODALITY THERAPY | ONCOLOGY | CONSOLIDATION RADIOTHERAPY | CELL TRANSPLANTATION | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | CHEMOTHERAPY | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Lymphoma - mortality | Antimetabolites, Antineoplastic - administration & dosage | Central Nervous System Neoplasms - radiotherapy | Lymphoma - drug therapy | Time Factors | Dose Fractionation | Female | Lymphoma - radiotherapy | Radiotherapy, Adjuvant | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Treatment Outcome | Chi-Square Distribution | Cranial Irradiation - adverse effects | Cytarabine - administration & dosage | Disease-Free Survival | Methotrexate - adverse effects | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Methotrexate - administration & dosage | Aged | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Germany | Chemotherapy | Radiation | Product development | Lymphomas | Methotrexate | Radiotherapy | Biometry | Cancer
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2017, Volume 179, Issue 4, pp. 586 - 597
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 2, pp. 111 - 121
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 20, pp. 2475 - 2482
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0180339
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Journal Article
Journal Article